Deep Learning-based HRCT Assessment of Baseline Disease Severity in the Deupirfenidone Elevate IPF Trial: Comparison With a Well-Characterised IPF Population

Science
8 August 2026
Deep Learning-based HRCT Assessment of Baseline Disease Severity in the Deupirfenidone Elevate IPF Trial: Comparison With a Well-Characterised IPF Population

This article is hosted externally.

View Article